2.2 Imminent generics entry Semaglutide, the biggest blockbuster product in the GLP-1 market today, is expected to lose patent protection in China in 2026, earlier than in most developed markets
Food reduces oral semaglutide absorption by up to 40%
The review covered a range of medications, including six trials on GLP-1 receptor agonists, one on dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists, one on orlistat, two on phentermine-topiramate, and one on naltrexone-bupropion
Vegetarian and plant-based dinner recipes Even if you are not vegetarian, adding plant-based dinners two to three times per week improves fiber intake and gut health
And then they spend two weeks hugging the toilet, wondering why this wonder drug feels like poison